Leveraging Affinity Interactions to Prolong Drug Delivery of Protein Therapeutics

While peptide and protein therapeutics have made tremendous advances in clinical treatments over the past few decades, they have been largely hindered by their ability to be effectively delivered to patients. While bolus parenteral injections have become standard clinical practice, they are insuffic...

Descripción completa

Detalles Bibliográficos
Autores principales: Dogan, Alan B., Dabkowski, Katherine E., von Recum, Horst A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144912/
https://www.ncbi.nlm.nih.gov/pubmed/35631672
http://dx.doi.org/10.3390/pharmaceutics14051088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144912/
https://www.ncbi.nlm.nih.gov/pubmed/35631672
http://dx.doi.org/10.3390/pharmaceutics14051088

Ejemplares similares